Pharmigene, Inc. (TPEX:7595)

Pharmigene Revenue

Pharmigene had revenue of 68.66M TWD in the half year ending June 30, 2026, with 43.18% growth. This brings the company's total for the last twelve months to 187.88M, up 25.88% year-over-year. In the year 2025, Pharmigene had annual revenue of 199.89M with 71.53% growth. That makes Pharmigene the 39,541st largest company in the world by revenue and 2,051st in Taiwan.

• Revenue (ttm): 187.88M
• Revenue Growth: +25.88%
• P/S Ratio: 2.16
• Revenue / Employee: n/a
• Employees: 42
• Market Cap: 406.24M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Taiwan 134.85M 67.5%
• America 62.54M 31.3%
• Asia 2.35M 1.2%
• Europe 157.00K 0.1%

Fiscal year ended Dec 31, 2025 See the full Pharmigene breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	199.89M	83.36M	71.53%
Dec 31, 2024	116.53M	-16.17M	-12.19%
Dec 31, 2023	132.71M	-1.09M	-0.82%
Dec 31, 2022	133.80M	4.45M	3.44%
Dec 31, 2021	129.35M	28.00M	27.63%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 5, 2026

Data Sources Report a data error